Nektar files $300M mixed securities shelf
EDT Nektar (NKTR) files $300M mixed securities shelfLight Up your Portfolio with Spark:Easily identify stocks' risks and opportunities.
The Pharma Letter1d
IL-2s gain ground as US market heads for $4 billion by 2034
The interleukin-2 (IL-2) therapies market in the USA is poised for major growth, projected to reach $4 billion by 2034, ...
Piper Sandler Remains a Buy on Nektar Therapeutics (NKTR)
In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Nektar Therapeutics (NKTR – Research Report), with a ...